B. Zingarelli, F. Squadrito, and P. Graziani, Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats, Agents and Actions, vol.28, issue.3-4, pp.150-156, 1993.
DOI : 10.1007/BF01998968

R. Zipser, C. Nast, and M. Lee, In vivo production of leukotriene B4 and leukotriene C4 in rabbit colitis, Gastroenterology, vol.92, issue.1, pp.33-39, 1987.
DOI : 10.1016/0016-5085(87)90836-5

H. Yuceyar, O. Ozutemiz, and A. Huseyinov, Is administration of n-3 fatty acids by mucosal enema protective against trinitrobenzene-induced colitis in rats? Prostaglandins Leukot Essent Fatty Acids, pp.339-345, 1999.

M. Kumlin, Measurement of Leukotrienes in Humans, American Journal of Respiratory and Critical Care Medicine, vol.161, issue.supplement_1, pp.102-106, 2000.
DOI : 10.1164/ajrccm.161.supplement_1.ltta-20

W. Best, J. Becktel, and J. Singleton, Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study, Gastroenterology, vol.70, pp.439-444, 1976.

D. Rachmilewitz, Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial., BMJ, vol.298, issue.6666, pp.82-86, 1989.
DOI : 10.1136/bmj.298.6666.82

G. Hardy, R. Boizel, and J. Bessard, Urinary leukotriene E4 excretion is increased in type 1 diabetic patients, Prostaglandins & Other Lipid Mediators, vol.78, issue.1-4, pp.291-299, 2005.
DOI : 10.1016/j.prostaglandins.2005.10.001

J. Hendel, I. Ahnfelt-ronne, and O. Nielsen, Expression of 5-lipoxygenase mRNA is unchanged in the colon of patients with active inflammatory bowel disease, Inflammation Research, vol.51, issue.8, pp.423-426, 2002.
DOI : 10.1007/PL00000324

S. Vermeire, G. Van-assche, and P. Rutgeerts, Laboratory markers in IBD: useful, magic, or unnecessary toys?, Gut, vol.55, issue.3, pp.426-431, 2006.
DOI : 10.1136/gut.2005.069476

D. Anthony, F. Savage, and P. Boulos, Effect of methylprednisolone on the ulceration, matrix metalloproteinase distribution and eicosanoid production in a model of colitis in the rabbit, International Journal of Experimental Pathology, vol.78, issue.6, pp.411-419, 1997.
DOI : 10.1046/j.1365-2613.1997.440373.x

K. Oketani, T. Inoue, and M. Murakami, Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide, European Journal of Pharmacology, vol.427, issue.2, pp.159-166, 2001.
DOI : 10.1016/S0014-2999(01)01234-1

K. Lauritsen, L. Laursen, and K. Bukhave, In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis., Gut, vol.28, issue.9, pp.1095-1099, 1987.
DOI : 10.1136/gut.28.9.1095

V. Singh, C. Patil, and S. Kulkarni, Effect of 5-lipoxygenase inhibition on events associated with inflammatory bowel disease in rats, Indian J Exp Biol, vol.42, pp.667-673, 2004.

R. Holma, P. Salmenpera, and A. Riutta, Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats, European Journal of Pharmacology, vol.429, issue.1-3, pp.309-318, 2001.
DOI : 10.1016/S0014-2999(01)01330-9

W. Roberts, T. Simon, and R. Berlin, Leukotrienes in ulcerative colitis: Results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591, Gastroenterology, vol.112, issue.3, pp.725-732, 1997.
DOI : 10.1053/gast.1997.v112.pm9041233

C. Hawkey, L. Dube, and L. Rountree, A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis, Gastroenterology, vol.112, issue.3, pp.718-724, 1997.
DOI : 10.1053/gast.1997.v112.pm9041232

Y. Almallah, S. Richardson, O. Hanrahan, and T. , Distal procto-colitis, natural cytotoxicity, and essential fatty acids, The American Journal of Gastroenterology, vol.334, issue.5, pp.804-809, 1998.
DOI : 10.1007/s002620050117